| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |